WASHINGTON (Reuters) - U.S. health officials have warned King Pharmaceuticals Inc that promotional material for its pain drug Avinza fails to warn consumers about the potential for abuse.
According to a letter from the U.S. Food and Drug Administration, the company failed to include any information about possible abuse of the drug -- a controlled substance -- and made unproven claims about how well it worked.
"The combination of such broad and unsubstantiated efficacy claims about the benefits of Avinza and the omission of the serious, potentially fatal risks associated with its use, as well as its potential for abuse, is especially egregious and alarming in its potential impact on the public health," it said.
The agency posted the March 24 letter on its Web site on Tuesday as part of its weekly update on companies, doctors and others who have drawn warnings from the agency.
YahooHave anyone seen warnings or removal of oxycotin from easy access to prevent abuse?